Y Intercept (Hong Kong) LTD Rhythm Pharmaceuticals, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding RYTM
# of Institutions
249Shares Held
63MCall Options Held
403KPut Options Held
62.8K-
Black Rock Inc. New York, NY6.74MShares$597 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$539 Million6.69% of portfolio
-
Primecap Management CO Pasadena, CA5.79MShares$513 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$496 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$305 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $4.94B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...